From: Insight into the mitochondrial unfolded protein response and cancer: opportunities and challenges
Inducers | Functional role | Impact | References |
---|---|---|---|
Abnormal respiratory chain | Dysregulation of OXPHOS | ROS accumulation, decrease in the mitochondrial membrane potential | [17] |
C8-SA | Activation of DAF-16 | Antioxidant stress | [16] |
FUS proteinopathies | Interference of ATP synthase complex formation | Inhibition of mitochondrial ATP synthesis | [26] |
Heat shock | Activation of HSF1, upregulation of mitochondrial chaperones | Maintenance of mitochondrial proteostasis | |
Inflammation | Involvement of TNF-α | ROS accumulation, overload of damaged proteins | [24] |
Microgravity stress | Not mentioned | ROS accumulation, decrease in locomotion behavior | [14] |
Mitochondrial-related genes knockout | Disorder of mitochondrial function | Imbalance of mitochondrial homeostasis | |
Nanopolystyrene | Activation of ELT-2 signaling, Wnt signaling, and insulin signaling | ROS accumulation, decrease in locomotion behavior | [13] |
Nicotinamide riboside | Activation of SIRT3 | Antioxidant stress | |
PolyQ | Direct interaction with the outer membrane of the mitochondria | ROS accumulation, decrease in the mitochondrial membrane potential | |
Statins | Inhibition of HMG-CoA reductase in the mevalonate pathway | Interference of mitochondrial electron carriers | [15] |
TDP-43 proteinopathies | Inhibition of ATP synthesis | abnormal cristae and a loss of cristae, ROS accumulation | [27] |